lovastatin has been researched along with B16 Melanoma in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (50.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fernandes, NV; Guntipalli, PK; Mo, H | 1 |
Dutta, D; Elfakhani, M; Fernandes, NV; Hynds, DL; Katuru, R; King, C; Mills, N; Mo, H | 1 |
Feleszko, W; Grzela, T; Hoser, G; Jakóbisiak, M; Jalili, A; Korczak-Kowalska, G; Lasek, W; Młynarczuk, I; Olszewska, D | 1 |
Akasaki, K; Michihara, A; Suenobu, M; Toda, K; Tsuji, H | 1 |
Czyzyk, J; Jakóbisiak, M; Kruszewski, AA; Lasek, W; Malejczyk, J; Sora, MK; Stokłosa, T | 1 |
Feleszko, W; Gołab, J; Jakóbisiak, M; Lasek, W | 1 |
Blanock, K; Gupta, V; Jani, JP; Katoh, A; Singh, SV; Specht, S; Stemmler, N | 1 |
Feleszko, W; Jakobisiak, M; Zagozdzon, R | 1 |
Feleszko, W; Gołab, J; Jakóbisiak, M; Zagozdzon, R | 1 |
Chen, Z; Jia, Z; Moyana, T; Saxena, A; Warrington, R; Xiang, J | 1 |
10 other study(ies) available for lovastatin and B16 Melanoma
Article | Year |
---|---|
d-δ-Tocotrienol-mediated cell cycle arrest and apoptosis in human melanoma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; G1 Phase; Humans; Lovastatin; Melanoma, Experimental; Telophase; Vitamin E | 2010 |
Mevalonate depletion mediates the suppressive impact of geranylgeraniol on murine B16 melanoma cells.
Topics: 3T3-L1 Cells; Alkaline Phosphatase; Animals; Apoptosis; Cell Cycle; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 4; Diterpenes; Humans; Lovastatin; Melanoma, Experimental; Mevalonic Acid; Mice; Vitamin E | 2011 |
Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis-dependent mechanism.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Doxorubicin; Drug Synergism; Female; Humans; In Situ Nick-End Labeling; Lovastatin; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neoplasm Metastasis; Tumor Cells, Cultured | 2002 |
Decrease of cholesterol in mouse melanoma causes secretion of lysosomal enzymes.
Topics: Animals; Anticholesteremic Agents; Cathepsin H; Cathepsins; Cell Line, Tumor; Cell Survival; Cholesterol; Culture Media; Cysteine Endopeptidases; Cytochrome P-450 CYP2B1; Endoplasmic Reticulum; Glucuronidase; Kinetics; Lipoproteins; Lovastatin; Lysosomes; Male; Melanoma, Experimental; Mice; Rats; Rats, Wistar | 2007 |
Synergistic antiproliferative activity of tumor necrosis factor alpha (TNF-alpha) and lovastatin.
Topics: Animals; Antineoplastic Agents; Cell Division; Drug Synergism; Growth Inhibitors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lamins; Leukemia L1210; Lovastatin; Melanoma, Experimental; Mice; Nuclear Proteins; Proto-Oncogene Proteins c-myc; ras Proteins; Recombinant Proteins; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1994 |
Synergistic antitumor activity of tumor necrosis factor-alpha and lovastatin against MmB16 melanoma in mice.
Topics: Animals; Antineoplastic Agents; Cell Division; Drug Synergism; Female; Lovastatin; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Recombinant Proteins; Survival Analysis; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1995 |
Metastasis of B16F10 mouse melanoma inhibited by lovastatin, an inhibitor of cholesterol biosynthesis.
Topics: Animals; Cell Adhesion; Cell Division; Female; Lovastatin; Melanoma, Experimental; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Tumor Cells, Cultured | 1993 |
Re: Greying of America will foster new strategies in oncology.
Topics: Aging; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Doxorubicin; Drug Synergism; Humans; Lovastatin; Melanoma, Experimental; Mice; Simvastatin | 1998 |
Potentiated antitumour effects of cisplatin and lovastatin against MmB16 melanoma in mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Synergism; Female; Lovastatin; Melanoma, Experimental; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Skin Neoplasms | 1998 |
Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cancer Vaccines; Cell Differentiation; Cell Movement; Dendritic Cells; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Interleukin-4; Lovastatin; Lung Neoplasms; Lymphocyte Activation; Melanoma, Experimental; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Necrosis; Phagocytosis; Receptors, CCR7; Receptors, Chemokine; T-Lymphocytes; TRPC Cation Channels; Tumor Cells, Cultured | 2001 |